Skip to main content
. 2019 Feb 21;10(2):347–354. doi: 10.1002/jcsm.12392

Table 1.

Clinical characteristics of all patients

All (n = 358) CH (n = 137) LC CP‐A (n = 169) LC CP‐B/C (n = 52)
Age, yearsa (SD) 70.8 (10.2) 70.8 (10.8) 71.1 (9.3) 69.8 (11.2)
Gender, male:female* 234:124 99:38 107:62 28:24
BMI, kg/m2 a (SD) 23.4 (21.0–25.6) 23.4 (3.5) 23.6 (3.3) 23.6 (3.8)
Aetiology, HCV:HBV:HBV&HCV:Alcohol:others 192:49:1:54:62 72:30:1:15:19 93:17:0:28:31 27:2:0:11:12
AST, IU/La (SD)** , **** 40.0 (27.8) 33.1 (22.6) 40.1 (25.5) 58.2 (37.9)
ALT, IU/La (SD)* 30.6 (24.2) 26.8 (20.4) 31.5 (26.4) 37.3 (24.9)
Platelets, 104/μLa (SD)** , *** 14.1 (6.0) 18.5 (5.0) 11.8 (4.7) 10.3 (5.0)
Total bilirubin, mg/dLa (SD)** , **** 0.98 (0.93) 0.7 (0.3) 0.9 (0.4) 2.0 (2.0)
Albumin, g/dLa (SD)** , *** , **** 3.99 (0.61) 4.28 (0.33) 4.05 (0.52) 3.08 (0.62)
Prothrombin time, %a (SD)** , *** , **** 84.7 (15.3) 92.3 (10.6) 84.3 (13.7) 69.0 (16.5)
History of HCC (%)**** 228 (63.7) 84 (61.3) 121 (71.6) 23 (44.2)
TNM stage in HCC patients, none:I:II:III:IV 266:25:37:14:16 102:11:12:4:8 124:12:18:8:7 40:2:7:2:1
HU by CTa (SD)** 47.1 (5.0) 47.5 (5.0) 47.3 (4.8) 45.4 (5.2)
Frequency of finger‐circle test results, Bigger:Just‐fits:Smaller 192:104:62 78:35:24 90:54:25 24:15:13
Frequency of MA, none:pre‐MA:MA 179:121:58 68:47:22 87:57:25 24:17:11
Positive for handgrip strength decline (%)* 152 (42.5) 48 (35.0) 75 (44.4) 29 (55.8)
With sarcopenia (%) 30 (8.4) 8 (5.8) 14 (8.3) 8 (15.4)

ALT, alanine transaminase; AST, aspartate aminotransferase; BMI, body mass index; CH, chronic hepatitis; CP, Child–Pugh classification; CT, computed tomography; HBV, hepatitis B virus; HCC, hepatitis C virus; HCV, hepatitis C virus; HU, Hounsfield units; LC, liver cirrhosis; MA, muscle atrophy.

a

Mean value.

*

P < 0.05 between CH and LC CP‐B/C.

**

P < 0.01 between CH and LC CP‐B/C.

***

P < 0.01 between CH and LC CP‐A.

****

P < 0.01 between LC CP‐A and CP‐B/C (Bonferroni's method).